AmpSeq

What AmpSeq does

AmpSeq is a US-based next-generation sequencing (NGS) services provider founded in 2023 and headquartered in Gaithersburg, Maryland, with additional offices in Cambridge, Massachusetts and Farmington, Connecticut. The company offers a horizontal portfolio of sequencing services spanning RNA-Seq (mRNA, total RNA, small RNA, single-cell, low-input, metatranscriptomics, and high-throughput variants), Whole Genome Sequencing (WGS) for viruses, bacteria, plants, and humans, Hi-C 3D genomics, targeted sequencing (including 16S/ITS microbial profiling and custom panels), Oxford Nanopore long-read workflows, and a sub-brand called AmpX offering express amplicon sequencing with three-day turnaround starting at $35 per sample. Services are delivered across Illumina (MiSeq, NextSeq, NovaSeq), Element AVITI, and Oxford Nanopore platforms, with end-to-end bioinformatics analysis from QC through differential expression and variant calling.

The business operates on a transactional, per-sample pay-as-you-go pricing model with no minimum sample requirements on entry-level services, and distributes through three channels: a self-serve AmpSeq Portal enabling order submission in under two minutes, direct email engagement with the in-house sequencing team, and a developing field sales motion targeting larger accounts. Customer segments are horizontal and include academic and research institutions, biotechnology and pharmaceutical companies, and individual researchers, supported by strategic partnerships with technology providers such as Illumina, 10x Genomics, Singleron, M20 Genomics, and Element.

AmpSeq's value proposition centers on industry-leading three-day turnaround times, accessible pricing, multi-platform flexibility, and over 15 years of stated pipeline expertise. The company is independently operated, with no disclosed venture funding beyond a December 2024 Montgomery County Technology Innovation and Founders Fund grant, and runs a lean team of 1-10 employees. As a private LLC in its second year of operation, AmpSeq sits in the early commercial stage, building a tri-state Northeast US footprint and scaling its product surface into structural and long-read genomics.

Name

AmpSeq

Legal name

AmpSeq, LLC

Website

https://ampseq.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

11–50 employees

Short description

AmpSeq is a US-based NGS services provider offering RNA-Seq, WGS, Hi-C, targeted sequencing, and Oxford Nanopore long-read workflows to academic researchers, biotech/pharma companies, and individual scientists, with fast turnaround and per-sample pricing across Illumina, Element AVITI, and ONT platforms.

Ownership category

akta.pro rank

Product category

Genomic Sequencing Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA)

akta.pro secondary industries

Transcriptomics & Gene Expression Profiling Services (HLAGANAE), Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

Keywords

• Next-generation sequencing
• RNA sequencing services
• Whole genome sequencing
• Amplicon sequencing
• Bioinformatics services

Headquarters

HQ city

Gaithersburg

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. NGS Sequencing Services: Per-sample and per-project pricing for NGS sequencing services across multiple modalities (RNA-Seq, WGS, Targeted Sequencing, Hi-C, AmpX, Sequencing-Only). Customers receive customized quotes based on project scope, sequencing depth, and data analysis requirements. Revenue is generated on a per-service basis with pricing starting at $35/sample.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

AmpSeq provides end-to-end next-generation sequencing (NGS) services for research customers, including library preparation, sequencing, and quality control. The company offers RNA-Seq (mRNA, total RNA, smRNA, single-cell, low-input, metatranscriptomics, high-throughput), whole genome sequencing (WGS), targeted sequencing (including AmpX express amplicon and 16S/ITS), Hi-C 3D genomics, sequencing-only runs for pre-made libraries, and Oxford Nanopore long-read workflows. Services are delivered with industry-leading turnaround times (as fast as 3 days) and integrated bioinformatics analysis.

Product overview

AmpSeq is a next-generation sequencing (NGS) services company offering an end-to-end portfolio spanning RNA Sequencing (RNA-Seq), Whole Genome Sequencing (WGS), Hi-C Sequencing (3D Genomics), Targeted Sequencing (including AmpX express amplicon sequencing, 16S/ITS, and custom amplicon panels), Sequencing Only (for pre-made libraries), and Oxford Nanopore Technology (ONT) workflows for long-read applications (ONT Full-Length 16S/ITS, ONT WGS, and ONT Whole Plasmid Sequencing). Services are delivered through the AmpSeq Portal online ordering platform. The company operates sequencing platforms including Illumina (MiSeq, NextSeq, NovaSeq), Element AVITI, and Oxford Nanopore Technologies, with an emphasis on fast turnaround times (as fast as 3 days) and affordable pricing.

Differentiator

Problem solved

Functional benefit

Brands

• AmpX: Express Amplicon Sequencing service offering rapid results in as fast as 3 days, with prices starting at $35/sample, for applications including CRISPR validation, 16S metagenomics, and antibody sequencing.

Products and services

• RNA Sequencing (RNA-Seq)

Quantifiable outcome

• Turnaround time as fast as 3 days across multiple service types
• +3 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Three partnerships are on record, tiered core.

• M20 GenomicscoreTechnology or IntegrationAmpSeq co-hosts events and collaborates with M20 Genomics on precision microbial genomics. M20 Genomics is referenced as a technology partner in AmpSeq's RNA-Seq service offerings, with their single-cell technology being used in scRNA-Seq workflows.
• 10x GenomicscoreTechnology or Integration10x Genomics is referenced on AmpSeq's RNA-Seq page as a technology partner used in single-cell RNA-Seq (scRNA-seq) workflows. The company profiles gene expression at the individual cell level using 10x Genomics-compatible approaches.
• IlluminacoreTechnology or IntegrationIllumina is listed as a sequencing platform partner, with MiSeq, NextSeq, and NovaSeq instruments used across AmpSeq's service offerings. The company is a key technology provider enabling AmpSeq's NGS services.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• CD Genomics: CD Genomics is an NGS services CRO offering RNA-Seq, WGS, scRNA-Seq, Hi-C, and targeted sequencing on Illumina, PacBio, and Nanopore platforms — directly comparable to AmpSeq's service breadth and customer base.
• Psomagen: Psomagen (formerly Macrogen US) provides NGS services including WGS, RNA-Seq, microbiome, and targeted panels to US research customers — directly comparable to AmpSeq in product offering and academic/biotech customer focus.
• Azenta (Genewiz) – Targeted Sequencing & Sanger: Already noted as a primary direct peer; also competing with AmpSeq's Targeted Sequencing and AmpX amplicon offering for clinical research and academic customers.
• Azenta Life Sciences (Genewiz): Azenta's Genewiz division is a leading commercial NGS services provider offering RNA-Seq, WGS, targeted panels, and bioinformatics for academic and pharma customers globally — directly competing with AmpSeq across the same core service menu and customer segments.
• Novogene: Novogene is a global NGS services provider offering WGS, RNA-Seq, exome, single-cell, and Hi-C with Illumina and PacBio platforms — a direct competitor to AmpSeq in research sequencing services for academic and biopharma customers.

Emerging players

• SeqCenter: SeqCenter is a small, fast-turnaround NGS services provider focused on microbial genomics, amplicon sequencing, and shotgun metagenomics — closely comparable to AmpSeq on AmpX-style rapid amplicon and 16S/ITS services with a similar SMB/academic focus.
• Element Biosciences: Element is a sequencing platform vendor (AVITI) and also operates Element Biosciences Services for sample-to-data NGS — a comparable emerging player because AmpSeq runs AVITI as a core platform and the vendor increasingly competes in the same service menu.

Broad incumbents

• BGI Genomics: BGI is the world's largest genomics organization, offering NGS services, sequencer manufacturing, and population genomics at scale — overlapping with AmpSeq on sequencing service offerings but operating as a global incumbent with proprietary DNBSEQ technology.
• Eurofins Genomics: Eurofins Genomics is a large, established genomics services arm within the broader Eurofins Scientific testing empire, offering Sanger, NGS, oligonucleotides, and bioinformatics — overlapping with AmpSeq on NGS service lines but with vastly broader scale and geographic reach.

Others

• Maine Molecular Quality Controls: MMQCI is an adjacent life-science tools provider making molecular controls for infectious disease and genetic testing — not a direct NGS services peer but operating in the broader molecular diagnostics ecosystem where AmpSeq's customer base operates.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/AmpSeq_NGS
• YouTubeyoutube.com/@AmpSeq
• Facebookfacebook.com/ampseq
• LinkedInlinkedin.com/company/ampseq
• Instagraminstagram.com/ampseq

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AmpSeq